Surgical Neurology
Volume 71, Issue 3 , Pages 332-336 , March 2009

Neuroprotective effects of infliximab in experimental spinal cord injury

  • Gökhan Kurt, MD

      Affiliations

    • Department of Neurosurgery, Gazi University Faculty of Medicine, 06500 Ankara, Turkey
    • ,
  • Ertan Ergün, MD

      Affiliations

    • Department of Neurosurgery, Gazi University Faculty of Medicine, 06500 Ankara, Turkey
    • ,
  • Berker Cemil, MD

      Affiliations

    • Department of Neurosurgery, Gazi University Faculty of Medicine, 06500 Ankara, Turkey
    • ,
  • Alp Özgün Börcek, MD

      Affiliations

    • Department of Neurosurgery, Gazi University Faculty of Medicine, 06500 Ankara, Turkey
    • Corresponding Author InformationCorresponding author. Gazi Üniversitesi Tıp Fakültesi, Beyin ve Sinir Cerrahisi AD 1. Kat, 06500 Ankara, Turkey. Tel.: +90 533 626 37 51; fax: +90 212 90 04.
    • ,
  • Pelin Börcek, MD

      Affiliations

    • Department of Pathology, Gazi University Faculty of Medicine, 06500 Ankara, Turkey
    • ,
  • Özlem Gülbahar, MD

      Affiliations

    • Department of Biochemistry, Gazi University Faculty of Medicine, 06500 Ankara, Turkey
    • ,
  • Necdet Çeviker, MD

      Affiliations

    • Department of Neurosurgery, Gazi University Faculty of Medicine, 06500 Ankara, Turkey

Received 29 October 2007 ,Accepted 7 January 2008.

References 

  1. Balentine JD. Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab Invest. 1978;39(3):254–266
  2. Bao F, Chen Y, Dekaban GA, Weaver LC. An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem. 2004;90(5):1194–1204
  3. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA. 1982;247(12):1707–1714
  4. Bracken MB. Steroids for acute spinal cord injury. Cochrane Database Syst Rev. 2002;(3):CD001046
  5. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol. 1998;151(1):77–88
  6. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001;344(12):907–916
  7. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med. 1997;3(1):73–76
  8. Demediuk P, Saunders RD, Clendenon NR, Means ED, Anderson DK, Horrocks LA. Changes in lipid metabolism in traumatized spinal cord. Prog Brain Res. 1985;63:211–226
  9. Demir T, Godekmerdan A, Balbaba M, Turkcuoglu P, Ilhan F, Demir N. The effect of infliximab, cyclosporine A and recombinant IL-10 on vitreous cytokine levels in experimental autoimmune uveitis. Indian J Ophthalmol. 2006;54(4):241–245
  10. Diaz-Ruiz A, Rios C, Duarte I, Correa D, Guizar-Sahagun G, Grijalva I, et al. Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone. Neuroreport. 2000;11(8):1765–1767
  11. Ducker TB, Kindt GW, Kempf LG. Pathological findings in acute experimental spinal cord trauma. J Neurosurg. 1971;35(6):700–708
  12. Faden AI, Simon RP. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann Neurol. 1988;23(6):623–626
  13. Fehlings MG, Tator CH, Linden RD. The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol. 1989;74(4):241–259
  14. Hall ED. Inhibition of lipid peroxidation in CNS trauma. J Neurotrauma. 1991;8(Suppl 1):S31–S40discussion S1
  15. Hall ED. Lipid antioxidants in acute central nervous system injury. Ann Emerg Med. 1993;22(6):1022–1027
  16. Hall ED. The neuroprotective pharmacology of methylprednisolone. J Neurosurg. 1992;76(1):13–22
  17. Hamada Y, Ikata T, Katoh S, Nakauchi K, Niwa M, Kawai Y, et al. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats. J Neurochem. 1996;66(4):1525–1531
  18. Holtz A, Nystrom B, Gerdin B, Olsson Y. Neuropathological changes and neurological function after spinal cord compression in the rat. J Neurotrauma. 1990;7(3):155–167
  19. Ildan F, Polat S, Oner A, Isbir T, Gocer AI, Tap O, et al. Effects of naloxone on sodium- and potassium-activated and magnesium-dependent adenosine-5¢-triphosphatase activity and lipid peroxidation and early ultrastructural findings after experimental spinal cord injury. Neurosurgery. 1995;36(4):797–805
  20. Kapadia MK, Rubin PA. The emerging use of TNF-alpha inhibitors in orbital inflammatory disease. Int Ophthalmol Clin. 2006;46(2):165–181
  21. Kaptanoglu E, Beskonakli E, Solaroglu I, Kilinc A, Taskin Y. Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev. 2003;26(4):283–287
  22. Kaptanoglu E, Caner HH, Surucu HS, Akbiyik F. Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury. J Neurosurg. 1999;91(2 Suppl):200–204
  23. Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev. 2004;27(2):113–120
  24. Kaptanoglu E, Tuncel M, Palaoglu S, Konan A, Demirpence E, Kilinc K. Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg. 2000;93(1 Suppl):77–84
  25. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM, et al. Stimulation of neutrophils by tumor necrosis factor. J Immunol. 1986;136(11):4220–4225
  26. Koc RK, Akdemir H, Karakucuk EI, Oktem IS, Menku A. Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury. Spinal Cord. 1999;37(1):29–32
  27. Kuek A, Hazleman BL, Ostor AJ. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J. 2007;83(978):251–260
  28. Kulmatycki KM, Abouchehade K, Sattari S, Jamali F. Drug-disease interactions: reduced beta-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat. Br J Pharmacol. 2001;133(2):286–294
  29. Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci. 1997;17(14):5395–5406
  30. Maini RN, Taylor PC. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med. 2000;51:207–229
  31. Markham A, Lamb HM. Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs. 2000;59(6):1341–1359
  32. Means ED, Anderson DK. Neuronophagia by leukocytes in experimental spinal cord injury. J Neuropathol Exp Neurol. 1983;42(6):707–719
  33. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271–278
  34. Mizuno Y, Ohta K. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J Neurochem. 1986;46(5):1344–1352
  35. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, et al. Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest. 1991;88(4):1396–1406
  36. Nesic O, Xu GY, McAdoo D, High KW, Hulsebosch C, Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J Neurotrauma. 2001;18(9):947–956
  37. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine. 2001;26(8):863–869
  38. Qian H, Liu D. The time course of malondialdehyde production following impact injury to rat spinal cord as measured by microdialysis and high pressure liquid chromatography. Neurochem Res. 1997;22(10):1231–1236
  39. Rawe SE, Lee WA, Perot PL. Spinal cord glucose utilization after experimental spinal cord injury. Neurosurgery. 1981;9(1):40–47
  40. Schmidley JW. Free radicals in central nervous system ischemia. Stroke. 1990;21(7):1086–1090
  41. Taoka Y, Okajima K. Spinal cord injury in the rat. Prog Neurobiol. 1998;56(3):341–358
  42. Taoka Y, Okajima K, Uchiba M, Murakami K, Harada N, Johno M, et al. Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J Neurosci. 1998;18(4):1393–1398
  43. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, et al. Role of neutrophils in spinal cord injury in the rat. Neuroscience. 1997;79(4):1177–1182
  44. Tator CH. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery. 1998;42(4):696–707discussion-8
  45. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75(1):15–26
  46. Usul H, Cakir E, Arslan E, Peksoylu B, Alver A, Sayin OC, et al. Effects of clotrimazole on experimental spinal cord injury. Arch Med Res. 2006;37(5):571–575
  47. Wang CX, Nuttin B, Heremans H, Dom R, Gybels J. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol. 1996;69(1-2):151–156
  48. Xu JA, Hsu CY, Liu TH, Hogan EL, Perot PL, Tai HH. Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem. 1990;55(3):907–912
  49. Yakovlev AG, Faden AI. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol. 1994;23(2-3):179–190
  50. Zheng H, Crowley JJ, Chan JC, Hoffmann H, Hatherill JR, Ishizaka A, et al. Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence. Am Rev Respir Dis. 1990;142(5):1073–1078
  51. Zileli M, Özer F. Pharmacological treatment in spinal cord injuries. In:  Zileli M,  Özer F editor. Spinal cord and spine surgery. Izmir: Saray; 1997;

PII: S0090-3019(08)00054-2

doi: 10.1016/j.surneu.2008.01.038

Surgical Neurology
Volume 71, Issue 3 , Pages 332-336 , March 2009

Article Tools